On August 1, 2013, BlueMountain Capital Management, LLC issued a press release announcing that it has delivered a letter to Taro Pharmaceutical Industries Ltd's Board of Directors, in which it has notified the Board that it intends to nominate 2 candidates to the Board of Directors in the role of external director. In addition, BlueMountain Capital stated that the Company has scheduled a shareholder vote to re-elect its external directors, Dan Biran and Ilana Avidov Mor, at its annual general meeting of shareholders to take place on September 9, 2013.